Products Categories
| CAS No.: | 6202-23-9 |
|---|---|
| Name: | Cyclobenzaprine hydrochloride |
| Molecular Structure: | |
|
|
|
| Formula: | C20H21N.HCl |
| Molecular Weight: | 311.88 |
| Synonyms: | Cyclobenzaprine Hydrochloride;3-(dibenzo[1,2-a:1',2'-e][7]annulen-11-ylidene)-N,N-dimethylpropan-1-amine,hydrochloride; |
| EINECS: | 228-264-4 |
| Melting Point: | 216-218°C |
| Boiling Point: | 405.9 °C at 760 mmHg |
| Flash Point: | 177.8 °C |
| Solubility: | Completely soluble in water |
| Appearance: | Crystalline Solid |
| Hazard Symbols: |
|
| Risk Codes: | R20/21/22 |
| Safety: | 36 |
| Transport Information: | UN 2811 6.1/PG 3 |
| PSA: | 3.24000 |
| LogP: | 5.35580 |
- 81281-59-67-Benzylideneaminotheophylline
- 82993-81-5D-threo-Ritalinic acid hydrochloride
- 73441-42-6METHYL-5-CHLORO-2,2-DIMETHYLVALERATE
- 68439-39-4Poly(oxy-1,2-ethanediyl), alpha-(2-ethylhexyl)-omega-hydroxy-,
- 852475-26-4MC1568
- 958254-66-51H-Imidazo[4,5-b]pyridine-2-carboxaldehyde, 1-methyl-, hydrochloride
- 99170-93-1N-Methyl-2-oxazolamine
- 717878-06-31-(4-fluorophenyl)-4-nitro-1H-imidazole
- 914458-26-7[5-(2-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naphthalenyl-Methanone
- 894852-01-87-BROMO-2,2-DIMETHYL-2H-PYRIDO[3,2-B][1,4]OXAZIN-3(4H)-ONE
What can I do for you?
Get Best Price
Specification
The Cyclobenzaprine hydrochloride with the cas number 6202-23-9, is also called (1)Amrix ; (2) Cloben ; (3) Cyben ; (4) Cyclobenzaprine HCl ; (5) Cyclobenzaprine hydrochloride ; (6) Cycloflex ; (7) Flexeril ; (8) Flexiban ; (9) Lisseril ; (10) MK 130 hydrochloride ; (11) Novo-Cycloprine ; (12) Proheptatrien monohydrochloride ; (13) Proheptatriene hydrochloride ; (14) Proheptatriene monohydrochloride ; (15) Tabradol ; (16) Tensodox ; (17) UNII-0VE05JYS2P ; (18) 1-Propanamine, 3-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride 10,11deltaAmitriptyline hydrochloride ; (19) 5-(3-Dimethylaminopropylidene)-5H-dibenzo-(a,d)cycloheptene hydrochloride;(20)N,N-Dimethyl-5H-dibenzo(a,d)cycloheptene-delta(sup 5,gamma)-propylamine hydrochloride. Cyclobenzaprine hydrochloride belongs to the following Product Categories: Heterocyclic Compounds;Intermediates & Fine Chemicals;Pharmaceuticals and so on.
Properties of Cyclobenzaprine hydrochloride are: (1)ACD/BCF (pH 5.5): 3.76 ; (2)ACD/BCF (pH 7.4): 66.96 ; (3)ACD/KOC (pH 5.5): 12.66 ; (4)ACD/KOC (pH 7.4): 225.6 ; (5)#H bond acceptors: 1 ; (6)#H bond donors: 0 ; (7)Flash Point: 177.8 °C ; (8)Enthalpy of Vaporization: 65.76 kJ/mol ; (9)Boiling Point: 405.9 °C at 760 mmHg ; (10)Vapour Pressure: 8.45E-07 mmHg at 25°C
Uses of Cyclobenzaprine hydrochloride: Cyclobenzaprine hydrochloride is a muscle relaxant, which is prescribed to relieve muscle spasms caused by injuries such as strains sprains, pulls. Combined with rest and physical therapy, it provides clinical relief of muscular stiffness and pain. Cyclobenzaprine hydrochloride is also can be used as reactant to obtain 5-[3-(N-Carbethoxy-N-methylamino)-propyliden]-dibenzo[a,d]cyclohepten. Cyclobenzaprine hydrochloride react with carbonochloridic acid ethyl ester with heating for 6 hour(s) in the toluene solvent.
.png)
You can still convert the following datas into molecular structure :
1. SMILES: Cl.c3cc\2c(\C=C/c1c(cccc1)C/2=C/CCN(C)C)cc3
2. InChI: InChI=1/C20H21N.ClH/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20;/h3-6,8-14H,7,15H2,1-2H3;1H
The Cyclobenzaprine hydrochloride toxic data can be showed in the following sheet.
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| man | TDLo | oral | 5714ug/kg/2D- (5.714mg/kg) | BEHAVIORAL: WAKEFULNESS BEHAVIORAL: EUPHORIA BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" | Journal of Clinical Psychiatry. Vol. 54, Pg. 39, 1993. |
| mouse | LD50 | intravenous | 36mg/kg (36mg/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 144, Pg. 481, 1963. | |
| mouse | LD50 | oral | 250mg/kg (250mg/kg) | "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 87, 1972. | |
| women | TDLo | oral | 1mg/kg/3D-I (1mg/kg) | BEHAVIORAL: WAKEFULNESS BEHAVIORAL: EUPHORIA BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" | Journal of Clinical Psychiatry. Vol. 54, Pg. 39, 1993. |
| women | TDLo | oral | 8400ug/kg/2W- (8.4mg/kg) | BEHAVIORAL: GENERAL ANESTHETIC | Journal of Clinical Psychiatry. Vol. 44, Pg. 151, 1983. |
| women | TDLo | oral | 12mg/kg (12mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP | Journal of Toxicology, Clinical Toxicology. Vol. 20, Pg. 281, 1983. |